The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback